CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Alnylam forecasts $4.7B-$5.1B in 2026 product revenue while targeting 25% TTR revenue CAGR through 2030

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 30, 2026 7:05 PM

Read Original